NDC11 33342019007
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 33342-0190-07 | 33342-0190 |
| 33342-0190-7 | 33342-0190 |
| 33342-190-07 | 33342-190 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AMLODIPINE and OLMESARTAN medoxomil | AMLODIPINE AND OLMESARTAN MEDOXOMIL | Macleods Pharmaceuticals Limited | c86a3c45-c906-46c9-9f7b-6c3d89bbe48f | 2026-01-03 | Boxed warning, Warnings, Adverse reactions | 33342-190-07 33342-190 33342019007 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.